Currently, this group includes variants in GBA and LRRK2. Given tremendous efforts to identify research cohorts, (e.g., by the Michael J. Fox Foundation-funded PPMI studies) our knowledge of the PD phenotype and the risk for PD among these mutation carriers has improved [14, 15]. The gene discussed is LRRK2; the disease is Parkinson disease.